Kerem Yildrim, Promega, Walldorf
At Promega, we are harnessing the power of AI to enhance efficiency, accuracy, and innovation across our research and development efforts. This presentation will explore our latest AI-driven initiatives, including the integration of ChatGPT for rapid literature analysis and a custom-built GPT model designed to generate structured insights on monoclonal antibody drugs. This specialized tool provides comprehensive summaries on drug targets, manufacturers, and mechanisms of action. Beyond research, we are extending AI applications to customer engagement—leveraging intelligent automation for prospecting and targeted content creation. By streamlining complex data analysis and reporting, our AI solutions reduce manual workload, accelerate decision-making, and optimize workflows throughout the organization.
